ULBP2-aCD33 was used as a negative control that failed to bind CD19+ MEC1 cells (U-33) whereas NKG2D-Fc and CD33-FLAG background binding was minimal (No IL). Triplebodies display better NK-cell-dependent killing of CLL and MLL target cells compared to bispecific counterparts Next, immunoligand-mediated and NK-cell-dependent antigen-specific killing of target cells was […]
Daily Archives: January 30, 2022
1 post